NVCR Stock Surges 28% For Best Day In Over 1.5 Years

NVCR stock surged 28%, marking its best day in over 1.5 years.

NVCR develops Tumor Treating Fields (TTFields) therapy for cancer.

Q2 was NVCR's strongest performance to date.